Results 11 to 20 of about 829,320 (360)

Outcome of adjuvant radiotherapy after total hysterectomy in patients with uterine leiomyosarcoma or carcinosarcoma: a SEER-based study

BMC Cancer, 2019
Background The clinical impact of adjuvant radiotherapy on uterine sarcoma is unclear, and may depend on the histological type. Hence, the aim of this study was to evaluate clinical outcomes of adjuvant radiotherapy after total hysterectomy in patients ...
Yuan Li, Haitao Ren, Junmei Wang
doaj   +2 more sources

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma [PDF]

New England Journal of Medicine, 2005
Glioblastoma, the most common primary brain tumor in adults, is usually rapidly fatal. The current standard of care for newly diagnosed glioblastoma is surgical resection to the extent feasible, followed by adjuvant radiotherapy. In this trial we compared radiotherapy alone with radiotherapy plus temozolomide, given concomitantly with and after ...
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, Van Den Weyngaert D, Kaendler S, Krauseneck P, Vinolas N, Villa S, Wurm RE, Maillot MHB, Spagnolli F, Kantor G, Malhaire JP, Renard L, De Witte O, Scandolaro L, Vecht CJ, Maingon P, Lutterbach J, Kobierska A, Bolla M, Souchon R, Mitine C, Tzuk-Shina T, Kuten A, Haferkamp G, de Greve J, Priou F, Menten J, Rutten I, Clavere P, Malmstrom A, Jancar B, Newlands E, Pigott K, Twijnstra A, Chinot O, Reni M, Boiardi A, Fabbro M, Campone M, Bozzino J, Frenay M, Gijtenbeek J, Brandes AA, Delattre JY, Bogdahn U, De Paula U, van den Bent MJ, Hanzen C, Pavanato G, Schraub S, Pfeffer R, Soffietti R, Weller M, Kortmann RD, Taphoorn M, Torrecilla JL, Marosi C, Grisold W, Huget P, Forsyth P, Fulton D, Kirby S, Wong R, Fenton D, Fisher B, Cairncross G, Whitlock P, Belanger K, Burdette-Radoux S, Gertler S, Saunders S, Laing K, Siddiqui J, Martin LA, Gulavita S, Perry J, Mason W, Thiessen B, Pai H, Alam ZY, Eisenstat D, Mingrone W, Hofer S, Pesce G, Curschmann J, Dietrich PY, Stupp R, Mirimanoff RO, Thum P, Baumert B, Ryan G   +108 more
openaire   +5 more sources

Influence of GSTP-1 Polymorphism on the Prognosis of Patients with High-Grade Glioma Who Received Temozolomide Plus Radiotherapy Adjuvant Treatment. [PDF]

Int J Gen Med, 2021
Background Glutathione S-Transferase P 1 (GSTP-1) gene plays an important physiological role in the body. The present study was conducted to identify the clinical implication of GSTP-1 gene polymorphism on the prognosis of patients with high-grade glioma
Zhi DB, Wang ZY, Xie T, Tu WW.
europepmc   +2 more sources

Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non–Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy

JAMA Oncology, 2021
This randomized clinical trial evaluates the effect of postoperative radiotherapy on survival and safety in patients with pIIIA-N2 non–small cell lung cancer after complete resection and adjuvant chemotherapy.
Z. Hui, Y. Men, Chen Hu, Jingjing Kang, Xin Sun, N. Bi, Zongmei Zhou, Jun Liang, J. Lv, Q. Feng, Z. Xiao, Dong-fu Chen, Yan Wang, Junling Li, Jie Wang, Shugeng Gao, Luhua Wang, Jie He   +17 more
semanticscholar   +1 more source

POSNOC—POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes

BMJ Open, 2021
Introduction ACOSOG-Z0011(Z11) trial showed that axillary node clearance (ANC) may be omitted in women with ≤2 positive nodes undergoing breast conserving surgery (BCS) and whole breast radiotherapy (RT).
A. Goyal, G. Mann, L. Fallowfield, L. Duley, M. Reed, D. Dodwell, R. Coleman, A. Fakis, R. Newcombe, V. Jenkins, D. Whitham, M. Childs, D. Whynes, V. Keeley, I. Ellis, P. Fairbrother, Shabina Sadiq, K. Monson, A. Montgomery, W. Tan, L. Vale, T. Homer, H. Badger, R. Haines, Mickey Lewis, D. Megias, Z. Nabi, Preetinder P. Singh, Andrei Caraman, E. Miles, Romaana Daniel Teresa Eleanor Rebecca Clare Clare Sarah Ai Mir Davis Grieve Mitchell Haydock Brittain Upton C   +30 more
semanticscholar   +1 more source

Adjuvant Radiotherapy after Surgical Excision in Keloids

Medicina, 2021
Keloids are a benign fibroproliferative disease with a high tendency of recurrence. Keloids cause functional impairment, disfigurement, pruritus, and low quality of life. Many therapeutic options have been used for keloids.
J. W. Lee, K. H. Seol
semanticscholar   +1 more source

Adjuvant Radiotherapy Improved Survival in Stage I to II Low-Grade Endometrial Stromal Sarcoma: A Retrospective Study of 152 Cases

Frontiers in Oncology, 2021
ObjectiveLow-grade endometrial stromal sarcoma (LG-ESS) is a rare gynecological tumor. Whether adjuvant radiotherapy benefits survival in patients with resected early-stage ESS remains controversial.
Wenhui Wang, Shuai Sun, Zheng Miao, Xiaorong Hou, Fuquan Zhang, Ke Hu   +5 more
doaj   +1 more source

Management after initial surgery of nonfunctioning pituitary adenoma: surveillance, radiotherapy or surgery?

Radiation Oncology, 2022
Introduction The first line of treatment for nonfunctioning pituitary adenoma (NFPA) is surgery. Adjuvant radiotherapy or surveillance and new treatment (second surgical operation or salvage radiotherapy) in case of recurrence are options discussed at ...
Thomas Charleux, Véronique Vendrely, Aymeri Huchet, Renaud Trouette, Amandine Ferrière, Antoine Tabarin, Vincent Jecko, Hugues Loiseau, Charles Dupin   +8 more
doaj   +1 more source

Analysis of the efficacy and factors influencing survival of adjuvant radiotherapy for stage II-III biliary tract carcinoma

World Journal of Surgical Oncology, 2023
Background To determine the efficacy of adjuvant radiotherapy for stage II–III biliary tract carcinoma. Methods We retrospectively analyzed the data of 37 patients who underwent radical resection of biliary tract carcinomas at the Affiliated Hospital of ...
Yan-Ling Guo, Jia-Xing Guo, Jian-Guo Zhao, Ying-Na Bao   +3 more
doaj   +1 more source

Tumor location as an indication for adjuvant radiotherapy in pT3N0 rectal cancer after surgery

Radiation Oncology, 2019
Background The optimal care for pT3N0 rectal cancer remains controversial. And whether tumor location can be used to guide the administration of adjuvant radiotherapy for pT3N0 rectal cancer is not fully confirmed.
Hai-hua Peng, Xin-hui Zhou, Tong-chong Zhou, Xing-sheng Qiu, Kai-yun You   +4 more
doaj   +1 more source